Boots is in early-stage discussions over a potential $10bn sale, as private equity owner Sycamore Partners weighs strategic exit options and steps back from earlier plans for a London IPO, according to a report by the Financial Times.
Potential bidders include the Canadian arm of the Weston family, through its investment vehicle Wittington Investments, as well as Australian pharmacy group Sigma Healthcare, both of which are exploring acquisitions as Boots becomes one of the largest UK retail ass...
Continue Reading
Sign up for FREE to read the full article and access 146K+ alternative investment headlines.